PMR Highlights

  • Over 60 clinical research facilities in USA, Canada, Australia,
    Mexico and Chile
  • Experience in Phase I, II, III, and IV clinical trials
  • Investigators have conducted more than 1,250 unique clinical trials
  • Over 31,000 patients followed in those trials
  • Consistently the top enrolling sites
  • Responsible for driving the subject recruitment timelines in
    many studies resulting in earlier submissions to regulatory
  • High quality data as evidenced by 56 regulatory inspections (FDA, Health
    Canada, & EMEA)
  • Key opinion leaders (KOL) who have consulted on compound
    development for over 270 pharmaceutical companies
  • Contribute to and guide protocol development for realistic and feasible
  • Present clinical data due to vast experience with products that are
  • Authorship

Get in touch with us

    By pressing the "Send" button, you confirm that you give the company your consents for processing your personal data.